About Liquid Biotech
Liquid Biotech is a company based in Audubon (United States) founded in 2015. Liquid Biotech has raised $2 million across 1 funding round from investors including Oncolys BioPharma. Liquid Biotech operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter Audubon, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2 M (USD)
in 1 rounds
-
Latest Funding Round
$2 M (USD), Seed
Dec 11, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Liquid Biotech
Liquid Biotech has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Liquid Biotech
Liquid Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Oncolys BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Oncolytic virus therapies for cancer and infectious diseases are developed.
|
Locked | Locked | Locked |
Investor details for Liquid Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Liquid Biotech
Investment portfolio details for Liquid Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Liquid Biotech
Detailed financials for Liquid Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Liquid Biotech Comparisons
Peer comparison for Liquid Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Liquid Biotech
Liquid Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
Detailed competitors of Liquid Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Liquid Biotech
Complete news archive for Liquid Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Liquid Biotech
Liquid Biotech was founded in 2015.
Liquid Biotech is headquartered in Audubon, United States. It is registered at Audubon, New Jersey, United States.
Liquid Biotech is a funded company, having raised a total of $2M across 1 funding round to date.
Liquid Biotech was founded in 2015 and is headquartered in Audubon, United States. Focus is placed on the biotechnology sector, particularly oncology diagnostics. Telomerase-based liquid biopsy tests are developed using recombinant viral vectors. These vectors enable fluorescence detection in circulating tumor cells, determined by telomerase activity levels. Services are directed toward non-invasive cancer monitoring and analysis.
Liquid Biotech's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
Liquid Biotech has 1 investor. Key investors include Oncolys BioPharma.